[2]
Muris P, Simon E, Lijphart H, Bos A, Hale W 3rd, Schmeitz K, International Child and Adolescent Anxiety Assessment Expert Group (ICAAAEG). The Youth Anxiety Measure for DSM-5 (YAM-5): Development and First Psychometric Evidence of a New Scale for Assessing Anxiety Disorders Symptoms of Children and Adolescents. Child psychiatry and human development. 2017 Feb:48(1):1-17. doi: 10.1007/s10578-016-0648-1. Epub
[PubMed PMID: 27179521]
[4]
Yeh SC,Li YY,Zhou C,Chiu PH,Chen JW, Effects of Virtual Reality and Augmented Reality on Induced Anxiety. IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society. 2018 Jul;
[PubMed PMID: 29985143]
[5]
LeBeau RT,Glenn D,Liao B,Wittchen HU,Beesdo-Baum K,Ollendick T,Craske MG, Specific phobia: a review of DSM-IV specific phobia and preliminary recommendations for DSM-V. Depression and anxiety. 2010 Feb;
[PubMed PMID: 20099272]
[7]
Minkova L,Sladky R,Kranz GS,Woletz M,Geissberger N,Kraus C,Lanzenberger R,Windischberger C, Task-dependent modulation of amygdala connectivity in social anxiety disorder. Psychiatry research. Neuroimaging. 2017 Apr 30;
[PubMed PMID: 28226306]
[8]
Ipser JC,Singh L,Stein DJ, Meta-analysis of functional brain imaging in specific phobia. Psychiatry and clinical neurosciences. 2013 Jul;
[PubMed PMID: 23711114]
Level 1 (high-level) evidence
[9]
El-Kordi A,Kästner A,Grube S,Klugmann M,Begemann M,Sperling S,Hammerschmidt K,Hammer C,Stepniak B,Patzig J,de Monasterio-Schrader P,Strenzke N,Flügge G,Werner HB,Pawlak R,Nave KA,Ehrenreich H, A single gene defect causing claustrophobia. Translational psychiatry. 2013 Apr 30;
[PubMed PMID: 23632458]
[10]
Wardenaar KJ,Lim CCW,Al-Hamzawi AO,Alonso J,Andrade LH,Benjet C,Bunting B,de Girolamo G,Demyttenaere K,Florescu SE,Gureje O,Hisateru T,Hu C,Huang Y,Karam E,Kiejna A,Lepine JP,Navarro-Mateu F,Oakley Browne M,Piazza M,Posada-Villa J,Ten Have ML,Torres Y,Xavier M,Zarkov Z,Kessler RC,Scott KM,de Jonge P, The cross-national epidemiology of specific phobia in the World Mental Health Surveys. Psychological medicine. 2017 Jul;
[PubMed PMID: 28222820]
Level 3 (low-level) evidence
[11]
Burstein M,Georgiades K,He JP,Schmitz A,Feig E,Khazanov GK,Merikangas K, Specific phobia among U.S. adolescents: phenomenology and typology. Depression and anxiety. 2012 Dec;
[PubMed PMID: 23108894]
[12]
Dewey M,Schink T,Dewey CF, Claustrophobia during magnetic resonance imaging: cohort study in over 55,000 patients. Journal of magnetic resonance imaging : JMRI. 2007 Nov;
[PubMed PMID: 17969166]
[13]
Murphy JM,Leighton AH, Anxiety: its role in the history of psychiatric epidemiology. Psychological medicine. 2009 Jul;
[PubMed PMID: 18940025]
[14]
Connolly SD,Bernstein GA, Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry. 2007 Feb;
[PubMed PMID: 17242630]
[15]
Rahani VK,Vard A,Najafi M, Claustrophobia Game: Design and Development of a New Virtual Reality Game for Treatment of Claustrophobia. Journal of medical signals and sensors. 2018 Oct-Dec;
[PubMed PMID: 30603615]
[16]
Thorpe S, Salkovskis PM, Dittner A. Claustrophobia in MRI: the role of cognitions. Magnetic resonance imaging. 2008 Oct:26(8):1081-8. doi: 10.1016/j.mri.2008.01.022. Epub 2008 Jun 3
[PubMed PMID: 18524527]
[18]
Boettcher H,Barlow DH, The unique and conditional effects of interoceptive exposure in the treatment of anxiety: A functional analysis. Behaviour research and therapy. 2019 Jun;
[PubMed PMID: 30579624]
[19]
Brown RKJ,Petty S,O'Malley S,Stojanovska J,Davenport MS,Kazerooni EA,Fessahazion D, Virtual Reality Tool Simulates MRI Experience. Tomography (Ann Arbor, Mich.). 2018 Sep;
[PubMed PMID: 30320208]
[21]
Sozio SJ,Bian Y,Marshall SJ,Rivera-Núñez Z,Bacile S,Roychowdhury S,Youmans DC, Determining the efficacy of low-dose oral benzodiazepine administration and use of wide-bore magnet in assisting claustrophobic patients to undergo MRI brain examination. Clinical imaging. 2021 Nov;
[PubMed PMID: 34198113]
[22]
Alamy S,Wei Zhang,Varia I,Davidson JR,Connor KM, Escitalopram in specific phobia: results of a placebo-controlled pilot trial. Journal of psychopharmacology (Oxford, England). 2008 Mar;
[PubMed PMID: 18208904]
Level 3 (low-level) evidence
[23]
de Quervain DJ,Bentz D,Michael T,Bolt OC,Wiederhold BK,Margraf J,Wilhelm FH, Glucocorticoids enhance extinction-based psychotherapy. Proceedings of the National Academy of Sciences of the United States of America. 2011 Apr 19;
[PubMed PMID: 21444799]
[24]
Stinson FS,Dawson DA,Patricia Chou S,Smith S,Goldstein RB,June Ruan W,Grant BF, The epidemiology of DSM-IV specific phobia in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychological medicine. 2007 Jul;
[PubMed PMID: 17335637]
Level 3 (low-level) evidence
[25]
Ollendick TH,Raishevich N,Davis TE 3rd,Sirbu C,Ost LG, Specific phobia in youth: phenomenology and psychological characteristics. Behavior therapy. 2010 Mar;
[PubMed PMID: 20171334]
[26]
Weinreb JC,Maravilla KR,Peshock R,Payne J, Magnetic resonance imaging: improving patient tolerance and safety. AJR. American journal of roentgenology. 1984 Dec;
[PubMed PMID: 6333798]